Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Breast Cancer
•
Radiation Oncology
Would you consider eliminating post lumpectomy RT in a premenopausal patient with pCR after chemotherapy for a cT1cN0 triple negative breast cancer?
Answer from: Radiation Oncologist at Community Practice
We don't have any prospective data on omitting RT in this case and would not consider this approach for triple negative patients.
Sign in or Register to read more
12900
Related Questions
What do you do when the dose constraints for heart and/or lung do not pass at all in a whole breast treatment planning?
Have you seen any increased dermatologic toxicity with whole breast or chest wall radiation if patients have received recent or concurrent pembrolizumab?
Do you offer APBI to patients with close margins?
Would you offer PMRT when the only indication is a focally positive margin?
In the era of hypofractionation for breast cancer, how would you re-irradiate for these cases if recurrence develops years later?
Can you safely proceed with breast irradiation during treatment with immunotherapy?
What are best practices for oncologists during the national platinum shortage?
Is there any situation where hypofractionation of post-mastectomy radiation (CW and regional nodes) is absolutely contraindicated?
Would you have a patient temporarily discontinue methotrexate while receiving a FAST or FAST FORWARD regimen for breast irradiation?
For a patient receiving postmastectomy IMRT to chest wall with expander and regional nodes including IMN, what constraint would you use for dose to the contralateral chest wall/implant if the patient also had a mastectomy and reconstruction on that side?